David Reese

Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells

Eric J. Small, Paige Fratesi, David Reese et al. · Journal of Clinical Oncology · 2000 · 625 citations

Medicine, Immunology, Oncology +17

Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer

M. Pegram, Tadeusz Pieńkowski, Donald W. Northfelt et al. · JNCI Journal of the National Cancer Institute · 2004 · 271 citations · Full text

Medicine, Oncology, Pharmacology +17

Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer

Marc Peeters, Kelly S. Oliner, Alex Parker et al. · Clinical Cancer Research · 2013 · 249 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Egbert F. Smit, David Khayat et al. · Journal of Clinical Oncology · 2010 · 222 citations

Medicine, Oncology, Pharmacology +17

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b

Cindy Wilson, Marc Payton, Gary Elliott et al. · Oncogene · 1997 · 194 citations

Life Sciences, Molecular Biology, Molecular Genetics +13